K220454 is an FDA 510(k) clearance for the Vivally System Wearable, Non-Invasive Neuromodulation System and Mobile Application. This device is classified as a Stimulator, Peripheral Nerve, Non-implanted, For Urinary Incontinence (Class II - Special Controls, product code NAM).
Submitted by Avation Medical, Inc. (Columbus, US). The FDA issued a Cleared decision on April 3, 2023, 410 days after receiving the submission on February 17, 2022.
This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.5310.